Pharmacological study of trunk bark of Acacia nilotica var adansonii (Guill et Perr).o Ktze (Mimosaceae): Assays, antioxidant and antispasmodic activities by Boly Abdoul, Gilchrist L et al.
Boly Abdoul et al                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):524-530 
ISSN: 2250-1177                                                                                   [524]                                                                                     CODEN (USA): JDDTAO 
Available online on 15.06.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                    Research Article 
Pharmacological study of trunk bark of Acacia nilotica var adansonii (Guill 
et Perr).o Ktze (Mimosaceae): Assays, antioxidant and antispasmodic 
activities 
Boly Abdoul Gilchrist L2⁎, Traore Aristide1, Ouedraogo Moussa2, Belemlilga Mohamed1,, Traore Tata K.2, 
Belemnaba Lazare.1, Ouedraogo Noufou.1, Lupu Andre3, Ouedraogo Sylvin1, Miron Liviu.3 et  Guissou Innocent P.1,2 
1 Institut de recherche en sciences de la santé (IRSS/CNRST), 03 BP7192 Ouaga 03, Burkina Faso  
2⁎ Ecole Doctorale de Santé, URF/SDS, Université de Ouagadougou, BP 7047, Burkina Faso  
3 Université des sciences agronomiques et médecine vétérinaire ‘’Ion Ionescu de la Brad’’ de Iasi Roumanie, code postal 700490 – Iaşi, 
Roumanie 
 
ABSTRACT 
Aim of this study was to evaluate in vitro polyphenols content, antioxidant and antispasmodic properties of the aqueous extract and fractions of 
the trunk bark of Acacia nilotica. According to a survey conducted in rural Burkina Faso, Acacia nilotica var. adansonii (Guill and Perr). Ktze 
reported to be widely used in the treatment of gastrointestinal diarrhoea and parasitosis. A maceration of the powder of the trunk bark of the 
plant was carried out. Then the aqueous macerate obtain, was fractionated with dichloromethane, butanol and ethyl acetate successively. The 
phenolic compounds of the aqueous extract, butanol and ethyl acetate fractions was determinated. The antioxidant activity of aqueous extract 
and fractions was evaluated by the DPPH, ABTS and FRAP tests. The contractility test on smooth muscle was realized according to Magnus 
method. Assay of the extracts revealed a high content of polyphenols, tannins and flavonoids. The aqueous extract, the butanol fractio n and the 
ethyl acetate fraction demonstrated a high antioxidant capacity. Aqueous extract showed a better antispasmodic effect of acetylcholine 
contraction induction at 1 μM (IC50 = 13.02 μg / mL) and for BaCl2 at 160 μg / mL (IC50 = 117.2 μg / mL). The aqueous extract of Acacia nilotica 
and his fractions had antioxidant properties. Only aqueous extract proven better antispasmodic property. Hence its use in traditional medicine 
in the treatment of diarrhoea. 
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INTRODUCTION 
The use of medicinal plants for the treatment of various 
diseases is the speciality of populations in developing 
countries such as Burkina Faso. Four hundred and twenty-
seven (427) species of plants are being used for the 
treatment of various diseases including gastrointestinal 
parasitosis in Burkina Faso1. In the search for new bioactive 
molecules against gastrointestinal parasitosis and diarrhoea, 
many researchs have been realize on the anthelmintic 
properties of certain plants. 
Acacia nilotica var adansonii (Guill and Perr) .O Ktze 
(Mimosaceae) plant, used in traditional medicine in the 
treatment of intestinal parasitosis and diarrhoea. It barks 
and pods used in rural areas in the treatment of diarrhoea, 
verminosis and gastritis2. Some of these antiparasitic 
properties including anthelmintic3 and antibacterial4 have 
already been proven. The objective of this study was to 
determinated polyphenols content and evaluated 
antispasmodic and antioxidant properties of the aqueous 
macerate of the trunk bark of Acacia nilotica var adansonii. 
Antioxidant activity evaluated by DPPH, ABTS and FRAPS 
tests. The study of smooth muscle contractility properties of 
the aqueous extract and its fractions were demonstrated by 
Magnus method 5. 
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MATERIALS AND METHODS  
Plant and preparation of fractions  
The Acacia nilotica var adansonii plant harvested at 140km 
from Ouagadougou in the Central-East region where the 
species is highly represented6. It has been identify under 
number HNBU00210 at the Herbarium of the National 
Center for Scientific and Technological Research (CNRST). 
The study extract prepared according to the traditional use. 
It aqueous maceration adopted for the extraction. One part 
of this extract has been fractioned. A test sample of 200 g of 
the plant material (bark powder) was macerate for 24 hours. 
The macerate obtains, was concentrate and fractionated by 
the liquid/liquid method. Fractionation of the aqueous 
extract used successively, dichloromethane solvents, ethyl 
acetate and butanol. The different fractions obtain were 
condense in a rotavapor and then oven-dried. 
Chemical reagents  
Tyrode solution composition was KCl (0.2g), NaCl (8g), 
MgCl2 (0.01g), NaHCO3 (1g), NaH2PO4 (0.05g), Glucose (1g) 
and CaCl2 (0.2g) in 1L of water distilled. It used as a survival 
medium for the isolated gut flap and atropine, papaverine as 
references. Reagents as well as DPPH (2,2-diphenyl-
picrylhydrazine), ABTS [2,2'-azinobis (3-ethyl benzoin-6-
sulphonate)], Trolox, quercetin, tannic acid, FCR 2N (Folin 
Ciocalteu reagent) were obtain with Sigma-Aldrich. 
Determination of phytochemical groups of aqueous 
extract, ethyl acetate and butanol fraction of Acacia 
nilotica var adansonii  
Total phenolics quantification 
The determination of total phenolics carried out according 
to the technique of Singleton et al7. In a test tube containing 
1 ml of 1 mg/ml concentration extract, 1 ml of 2N FCR (Folin 
Ciocalteu reagent) and 3 ml of a 20% sodium carbonate 
solution added. The mixture made in triplicate with also a 
white control with distilled water. After 40 min incubation at 
room temperature of the mixture, the absorbance at 760 nm 
measured with the spectrophotometer. From the standard 
curve plotted with tannic acid, the total phenol 
concentration of the extract provided by the formula: 
                                               TPT          ⁄      
TPT : total phenol content of the extract expressed in tannic 
acid equivalent (EAT)/g ; CTube : is the concentration in mg 
EAT/mL in the assay tube ; D : the dilution factor ; Ci : the 
concentration in  mg/mL in the stock solution  
Quantification of tannins  
The method described by Tibiri et al 8 adopted for the 
determination of tannins. It based on the precipitation of 
tannins with polyvinyl polypyrrolidone (PVPP) by the 
formation of a complex. The complexion of 2 mg of tannin 
requires 100 mg of PVPP. Thus, in a 1ml volume of an extract 
of concentration 1mg / ml, a sufficient amount of PVPP 
added there to and then stirred. After 15 minutes incubation 
at 4 °C., the mixture centrifuged at 3000 g for 10 minutes. As 
the tannins precipitated, the supernatant was recover for a 
total phenolics assay other than tannins7. The difference 
between the first value of the total phenolic compounds 
(which contained the tannins) and the second value of the 
total phenolics (in the absence of the tannins) gives the 
tannin content. 
Quantification of flavonoids   
The total flavonoids was determined according to the 
method described by Abdel-Hameed9. In a test tube, a 
mixture of 100 μl of an extract of concentration 1 mg/ml in 
water was prepared with 100 μl of 2% aluminium 
trichloride (AlCl3) in methanol (CH3OH). The volume of the 
mixture brought to 5 mL with methanol after adding a drop 
of acetic acid (CH3COOH). A white witness made parallel 
with the water. The mixtures allowed incubating for 40 min 
before measuring the absorbance at 415 nm 
spectrophotometer. A standard curve plotted with quercetin 
and used as the reference compound. The content of 
flavonoids in the extract is determined in Equivalent 
Quercetin (EQ) according to the following formula:    
                                                    TFl= (        ⁄ )     
TFlav : the total flavonoid content of the extract expressed in 
equivalent quercetin (EQ)/g ; CTube : the concentration in mg 
EQ/mL in the assay tube ; D : the dilution factor ; Ci : the 
concentration in  mg/mL in the stock solution  
Antioxidant activity  
Evaluation of the anti-radical activity by radical DPPH° 
inhibition (2,2-Diphénylpicrylhydrazine)  
It performed according to the method described by Kim et 
al10. A cascade dilution of the extracts and Trolox (positive 
control) of concentration 1 mg/mL were performed. A 
solution of DPPH (4mg in 100mL of methanol) was 
Prepared. Then, on a 96-well microplate, a reaction mixture 
of 20 μL of each dilution of the extracts and Trolox with 200 
μL of the DPPH solution made. The mixture allowed 
incubating for 30 minutes with methanol used as white. The 
absorbance reading is then 490 nm to the photo 
spectrometer (Agilent 8453). The percentage inhibition 
calculated according to the formula: 
                                                   ⁄  ×100 
A0 : the absorbance of the negative control ; A1 : the 
absorbance of the sample 
The antiradical power (ARP) was calculated by the formula: 
                                                          ⁄  
ARP: anti-radical power ; IC50 : inhibitory concentration of  
50% DPPH° expressed in µg/mL of extract. 
Evaluation of the anti-radical activity by the radical 
ABTS reduction  
In an Erlenmeyer flask containing 5 ml of distilled water, 
12.2 mg of ABTS [2,2'-azinobis- (3-ethylbenzothiazoline-6-
sulfonic acid)] are dissolved therein. Then 3,312mg of 
potassium persulfate added. The mixtures were obtained 
kept for 12 to 16 hours of time away from light and at room 
temperature. A volume of 4.5 ml of the mixture diluted in 
220 mL of ethanol for carrying out the ABTS test. According 
to the method described by Re et al.11, a cascade dilution of 
the extracts and Trolox (positive control) of concentration 1 
mg/mL were made. On a 96-well microplate, a reaction 
mixture is prepared with 20 μL of each dilution and 200 μL 
of the ABTS solution plus diluted in triplicate. The reaction 
mixture was allowed incubating at room temperature for 30 
minutes, in the dark. Activity monitoring did at the photo 
spectrometer at 432nm wavelength. The following formula 
used to determine the inhibition percent: 
                                                         ⁄  ×100 
A0 : is the absorbance of the negative control  ; A1: the 
absorbance of the sample. 
The anti-radical power (ARP):  
                                                           ⁄  
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Evaluation of the reducing power of iron (FRAP) 
The method described by Apati et al12 which were adopted. 
In a volume of 0.5 mL of extract and concentration 1 mg / 
mL, a volume of 1.25 mL of phosphate buffer (0.2 M, pH 6.6) 
and 1.25 mL of potassium hexacyanoferrate [K3 Fe(CN)6 ] 
1% in water added. After incubating the mixture in a water 
bath at 50° C. for 30 minutes, 1.25 mL of trichloroacetic acid 
(10%) added thereto. Then the whole was centrifuged at 
3000 rpm for 10 minutes. After the centrifugation, a volume 
of 0.625 mL of the mixture diluted in 0.625 mL of distilled 
water contained in an Eppendorf tube. 0.125 mL of freshly 
were prepared 1% FeCl3 in water added for instantaneous 
reading at the 700 nm photopetrometer. From a standard 
curve of established ascorbic acid, the reducing power of the 
extract was determined and expressed in mmol Equivalent 
ascorbic acid (EAA) per gram of dry extract (mmol ascorbic 
acid / g dry extract) according to the formula: 
                                                ⁄        
C : concentration of reducing compounds in  mmol EAA/g of 
solids  ; c :concentration of the extract read ; D : dilution 
factor of the stock extract solution ; Ci : concentration of the 
mother extract solution  ; M : molar mass of ascorbic acid 
(176.12g/mol). 
 
Antispasmodic activity  
The use of the rat for the test was in accordance with 
internationally accepted principles for the use and care of 
laboratory animals as defined by the European Community 
Directives (1986 EEC Directive, 86/609 / EEC).This study 
carried out according to the method described by Magnus5. 
It consists in evaluating the relaxing effect of the extract, on 
a contraction phase of contraction of the isolated rat 
duodenum, induced by a contracting agent. To evaluate the 
relaxing effect of the aqueous extract and fractions, 
cumulative concentrations of each extract (260 µg/mL, 560 
µg/mL, 1160 µg/mL, 1960 µg/mL, 2960 µg/mL) injected 
into the isolated organ the isotonic phase and then in 
contraction tonic phase of the duodenum induced with 
acetylcholine (1 mM) or BaCl2 (160 μg / mL). The peak 
obtained at the recorder level with each extract compared 
with that previously created by acetylcholine (Ach). The 
references used were atropine and papaverine. The 
percentage inhibition of contraction (PI) calculated 
according to the formula: 
                                         PI= (h1 – h2 /h1) × 100  
h1 : height of the peaks due to the contractor alone;  ; h2 : 
heights of the peaks due to the contractor in the presence of 
the extract. 
Analysis of the Results  
Calculations of percentages of inhibitions and equivalents of 
tannic acid, quercetin and ascorbic acid performed with the 
MS Excel software (CORREL statistical function). The results 
of the pharmacological study expressed as mean ± Standard 
Mean Error (E.S.M.). The different figures were plotted using 
GraphPad Software Prism version 5.01.The series 
considered significant when the probability of error (p) is 
lower than the agreed risk: 0.05 (p <0.05). 
RESULTS  
Quantification of total polyphenols, tannins and total 
flavonoids  
Total phenolic, tannin and flavonoid content of extract and 
fractions showed in Table 4. 
  
Table 2: Total phenolic, tannin and flavonoid content 
 Phenols T  
(mg ETA/g) 
Tannin 
(mg ETA/g) 
Flavonoid 
(mg QE/g) 
   
AE 573.03±9.88 519.98±8.86 
 
13.65±8.08 
 
   
EAF 948.94±5.05 
 
633.37±1.96 
 
10.32±2.39 
 
   
BF 769.23±21.96 625.23±21.75 20.71±1.29    
EAF: ethyl acetate fraction; BF: butanolic fraction; AE: Aqueous extract; ETA: Equivalent tannic acid; EQ: Quercetin Equivalent 
Antioxidant assay  
Evaluation of the anti-radical activity DPPH° 
The better anti-radical activity obtain with ethyl acetate 
fraction It’s better than de Trolox. Aqueous extract showed a 
low anti-radical activity. 
Evaluation of the anti-radical activity ABTS  
ABTS test showed good anti-radical activity of the ethyl 
acetate fraction and Aqueous extract. However, their anti-
radical activity was less than Trolox anti-radical activity  
Reducing power by the FRAP method (Ferric Reducing 
Antioxydant Power) 
The reducing power of the iron extracts was expresse in 
mole equivalent ascorbic acid. The ethyl acetate fraction 
expressed the highest reducing, followed by the butanol 
fraction and the aqueous extract.
 
Table 4: Summary of antioxidant activity values DPPH, ABTS, FRAP 
                      DPPH                  ABTS      FRAP 
Extrait IC50 (µg/mL) ARP IC50 (µg/mL) ARP mmol EAA/mL 
AE 8.19±0.87 0.12 5.81± 0.11 0.17 1231.46±0.23 
EAF 2.07± 0.19 0.48 5.65± 0.02 0.18 1421.81±0.07 
BF 4.33±0.08 0.23 10.86±0.17 0.09 1390.87±0.02 
Trolox 5.69±0.21 0.18 3.78±0.06 0.27  
EAF: ethyl acetate fraction; BF: butanolic fraction; AE: Aqueous extract; EAA: Equivalent ascorbic acid; ARP:  Anti-radical Power 
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In vitro study of antispasmodic activity of aqueous extract, ethyl acetate and butanol fraction of Acacia nilotica var 
adansonii, on intestinal smooth muscle  
Effect of extracts and atropine on acetylcholine-induced duodenum contraction  
Different concentrations of the aqueous extract and the butanolic fraction induced the relaxation of the muscle.  Aqueous 
extract showed good relaxation (IC50 = 13.02 μg/mL; Fig 1) than butanolic fraction (IC50 = 96.03 μg/mL; Fig 2). It is however, 
less better than atropine relaxation induced (IC50 = 1.018 μg/mL; Fig 3). The ethyl acetate fraction did not show effect on 
muscle contraction.  
 
    
 
Figure 1 : Dose-effect profile of aqueous  
       extract relaxation on Ach-induced 
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Photo 3: Inhibition of ach-induced contraction by atropine  
Figure 3: Dose-effect profile of atropine relaxation on Ach-
induced  
Photo 1 : Inhibition of ach-induced smooth muscle 
contraction by extract. 
 
                         
1cm/sec 
Figure 2 : Dose-effect profile of butanol fraction relaxation 
on Ach-induced 
Photo 2: Inhibition of ach-induced contraction by butanol 
fraction 
 
  Ach                              260  560  1160  1960 2960 µg/mL 
                     Ach           260  560 1160 1960 2960 µg/mL 
                   Ach              2     5     9    16    24  10-3 µg/mL 
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Effect of extracts and papaverine on BaCl2-induced duodenum contraction  
Only aqueous extract (Fig 4) has been get inhibitory effect on the duodenum contraction, induced by 160 μg/mL BaCl2 (IC50 = 
117.2 μg/mL). The ethyl acetate and butanol fraction did not show any effects with BaCl2 contraction (Data not show). 
Nevertheless, papaverine showed good relaxation (IC50 = 2.054 μg/mL) with BaCl2 induction (Fig 5). 
 
   
 
 
 
 
DISCUSSIONS 
The phytochemical groups quantification showed that, 
aqueous extract have a higher tannins content (519.98 ± 
8.86 mg EAT/gE) than flavonoids (13.65 ± 8.08 mg EQ / g). 
This means that more than half of the polyphenols measured 
would be tannins. Flavonoids would represent less than 
10%. It is also remark by Mukundi et al, in the 
hydroethanolic leaf extract where the total phenolic content 
was 2.16 mg / g with 2.06 mg / g tannin content and 0.29 mg 
/ g dry matter total flavonoids13. According to Serémé et al., 
the bark of Acacia nilotica trunks is rich in tannins after 
these fresh fruits among the tanniferous plants of Burkina 
Faso, ie 28.7% of the weight of the dry matter14. Conformity 
therefore, the name of "tannin plant". In the methanolic 
extract of the Acacia nilotica var nilotica trunk bark15, the 
total phenolic content (945mg EAG / g) is more than 
aqueous extract of the adansonii variety (519.98 ± 8, 86 mg 
EAT / g). Omara et al16, also remarked this high total 
phenolic content in fruit of Acacia nilotica  (504.99 mg EAG / 
g) with a flavonoid content equal to 243 mg Rutin equivalent 
/ g. 
The low proportion of flavonoids in the polyphenols found is 
different to the results obtained by Sadiq et al., with 
hydroethanolic extract of the bark of the nilotica variety17. It 
was 62.03 mg EAG / g polyphenol content and 45.5mg EQ / g 
for flavonoids.  Flavonoids content represented more than 
half of the polyphenols in this study. It could be explain by 
the difference in the plant variety. The nilotica variety bark, 
therefore, has a higher flavonoid content than adansonii 
variety. 
Antioxidant essay by antiradical methods (DPPH and ABTS) 
and iron reduction method (FRAP), allows better evaluation 
of the antioxidant potential of the extracts. The ethyl acetate 
fraction showed both of DPPH (IC50 = 2.07 ± 0.19 μg / mL) 
and ABTS (IC50 = 5.65 ± 0.02 μg / mL), better antiradical 
activity than butanolic fraction and aqueous extract. To the 
DPPH free radical test, the fraction of ethyl acetate and the 
butanolic fraction (IC50 = 4.33 ± 0.08 μg / mL) presented 
better antiradical activity than Trolox (IC50 = 5.69 ± 0.21 μg/ 
mL). However, in the ABTS test, the antiradical activity of 
Trolox (IC50 = 3.78 ± 0.06 μg / mL) were better than of ethyl 
acetate fraction (IC50 = 5.65 ± 0.02 μg / mL) and the butanol 
fraction (IC50 = 10.86 ± 0.17μg / mL). The aqueous extract 
had a good antiradical activity on ABTS radical (IC50 = 5.81 ± 
0.11 μg / ml) than on DPPH radical (IC50 = 8.19 ± 0.87 μg / 
mL). This means that, fractions and aqueous extract have 
hydrogen proton donor chemical groups18. The antiradical 
activity of the aqueous extract of the adansonii variety on 
the DPPH radical would be better than of methanolic extract 
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Figure 4: profile of atropine relaxation on BaCl2  -
induced by the extract 
Photo 4: Inhibition of BaCl2-induced contraction  by the 
extract 
 Ach                    2       5      9     16      24   µg/mL 
Figure 5: profile of atropine relaxation on BaCl2  -
induced by the papaverine 
Photo 4: Inhibition of BaCl2-induced contraction  by the 
papaverine 
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of the leaves (IC50 = 350 μg / mL) and barks (IC50 = 1410 μg / 
mL) of the nilotica variety17. Furthermore the ABTS 
antiradical activity of the butanolic fraction (IC50 = 12.74 ± 
0.01 μg / mL) and the ethyl acetate fraction (IC50 = 12.73 ± 
0.01 μg / mL) are lower than of the bark extract of the 
adansonii variety19. To the DPPH radical, antiradical activity 
of the extracts of the bark of the adansonii variety is better 
than of butanolic fraction (IC50 = 83.3 ± 1.15 μg / mL), ethyl 
acetate (IC50 = 90.26 ± 2.41 μg / mL) and the aqueous 
fraction (IC50 = 59.15 ± 0.87 μg / mL) of the nilotica variety19. 
The iron reduction test (FRAP) showed high reducing power 
of the ethyl acetate fraction (1421.81 ± 0.07 mmol EAA / 
mL), butanolic fraction (1390.87 ± 0.02 mmol EAA / mL) and 
aqueous extract (1231.46 ± 0.23 mole EAA / mL). These 
activities are higher than of gallic acid (18.46a ± 1.51 mmol 
EAA / mL) and quercetin (13.19 ± 2.17 mmol EAA / mL) 
activities20. This reducing power of acacia nilotica extract, 
linked to the presence of reductone molecules21. These 
reductones would act on the free radical chains by donation 
of hydrogen atom causing their breaks22. In all three 
antioxidant activities, aqueous extract and fractions had 
good antioxidant activity. The phenolic compounds and an 
especially high gallic acid content would be responsible, for 
this strong antioxidant activity of bark extract aqueous of 
Acacia nilotica var adansonii. The results indicates a close 
link between the antioxidant activity and total phenol 
content of the extracts. This correlation between antioxidant 
activity and total phenolic content evoked and proven by 
many authors23,24,25.  
Aqueous extract of Acacia nilotica var adansonii and 
butanolic fraction inhibit acetylcholine-induced contraction 
on smooth muscle of rat duodenum. This interaction with 
cholinergic system means that aqueous extract and the 
butanolic fraction are acetylcholine blockers. The effective 
inhibitory concentration (IC50) of the aqueous extract was 
13.02 μg / mL and of butanol fraction was 96.03 μg /mL. 
Atropine showed an IC50 = 1.02 μg / mL. This means that 
aqueous extract is just 10 times less potent than atropine. 
The compounds of the aqueous extract could also act as 
atropine. They could block the Ach by direct competition on 
muscarinic M3 receptors. Further investigation required. 
Because it could be another indirect anticholinergic pathway 
action. Such as inhibition of calcium mobilization in calcium 
channels. The butanol fraction is less potent than the 
aqueous extract and almost 10 times less than atropine. 
Furthermore, it relaxation effect does not reach 100%, 
unlike aqueous extract and atropine. It would mean that 
fractionation causes the decrease of the anticholinergic 
activity of the aqueous extract. This confirmed by the 
absence of anticholinergic effect with ethyl acetate fraction. 
The aqueous extract is also shown to be a better inhibitor of 
Ach compared to certain plants, such as Erythrina indica lam 
(IC50 = 79.7 μg / mL)26, Piper sarmentosum (IC50 = 88 μg / 
mL)27, Blumea lacera (IC50 = 76.19 μg / mL). 
In addition, aqueous extract of Acacia nilotica inhibited 
smooth muscle contraction, by BaCl2-induced. The inhibitory 
concentration IC50 = 117.2 μg / mL. This concentration of 
inhibition is significantly higher than of papaverine which 
was IC 50 = 2.054 μg / mL. It is means that inhibitory effect 
of aqueous extract less potent than of papaverine. The 
aqueous extract would also act on myocytes to allow smooth 
muscle relaxation. It could act as papaverine, inhibiting the 
functioning of phosphodiesterase. This way of action on 
myocytes said musculotropic. It is better than plant Blumea 
lacera (IC50 = 120.2 μg / mL)28 or Teucrium stocksianum 
which have no effect by this musculotropic pathway29. 
According to Zhu et al30, tannins could be responsible for the 
spasmolytic activity of the aqueous extract and flavonoids31. 
However, this spasmolytic effect of flavonoids and tannins 
does not appear proportionally to their contents in the 
extracts. Because only the aqueous extract whose tannins 
and flavonoids content were low compared to ethyl acetate 
and butanol fractions, showed a more significant 
spasmolytic effect. This means that the spasmolytic effect of 
the aqueous extract could result from other phytochemical 
groups such as glycosides31 or alkaloids. The effect could 
also result from a synergy  action between the different 
phytochemical groups, which make up the extract. 
CONCLUSION 
The results of this study indicate that the aqueous extract of 
the trunk bark powder of Acacia nilotica var adansonii has 
both antispasmodic and antioxidant properties compared to 
its ethyl acetate fraction and butanol. The measured and 
identified polyphenol groups or other phytochemical groups 
would be responsible for these antioxidant and 
antispasmodic properties of the aqueous extract. Therefore, 
it a plant, which used in traditional medicine against 
parasitosis and diarrhoea justified. Further investigations, 
will be better to demonstrate the antispasmodic and 
antiparasitic action mechanism of the aqueous extract of 
acacia nilotica var adansonii. 
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